Long-term use of oral nucleos(t)ide analogues for the treatment of chronic hepatitis B virus (HBV) may increase the risk of colorectal and cervical cancer, according to new study presented at The International Liver Congress in Barcelona, Spain. Prolonged treatment with nucleos(t)ide analogues to prevent the virus from reproducing are recommended in some patients with chronic HBV, but questions have been raised about the safety of long-term use. This prompted researchers with the Department of Medicine & Therapeutics Academic at the Chinese University of Hong Kong to investigate the risks. The study involved more than 45,000 patients with chronic HBV. Of ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.